CD40 Antikörper (FITC)

Produktnummer ABIN473641

Dieses Maus Monoklonal-Antikörper erkennt spezifisch CD40 in FACS. Er zeigt eine Reaktivität gegenüber Human.

Kurzübersicht für CD40 Antikörper (FITC) (ABIN473641)

Target: CD40

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser CD40 Antikörper ist konjugiert mit FITC

Applikation: Flow Cytometry (FACS)

Klon: 5C3

Produktdetails anti-CD40 Antikörper (FITC)

Aufreinigung: Affinity purified

Immunogen: Human CD40

Isotyp: IgG1 kappa

Anwendungsinformationen

Applikationshinweise: Approved: Flo

Usage: The 5C3 antibody has been pre-titrated and tested by flow cytometric analysis of human peripheral blood leukocytes. This can be used at 5 μL (0.5 μg)/per test. A test is defined as the amount (ug)/test of antibody that will stain a cell sample in a final volume of 100 μL. Cell number should be determined empirically but can range from 10^5 to 10^8 cells/test. The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.

Kommentare:

Target Species of Antibody: Human

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: Lot specific

Buffer: PBS,  pH 7.2, 150 mM sodium chloride, 0.09 % sodium azide, 0.2 % BSA

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Do not freeze. Product is photosensitive and should be protected from light.

Lagerung: 4 °C

Informationen zur Lagerung: Store at 4°C. Do not freeze. Protect from light.

Details zu CD40

Target: CD40

Andere Bezeichnung: CD40

Hintergrund: Name/Gene ID: CD40
Family: TNF Receptor

Synonyms: CD40, B-cell surface antigen CD40, B cell-associated molecule, B cell surface antigen CD40, CD40 antigen, CD40 type II isoform, p50, Bp50, CD40L receptor, CDW40, TNFRSF5

Gen-ID: 958

UniProt: P25942

Pathways: NF-kappaB Signalweg, Cellular Response to Molecule of Bacterial Origin, M Phase, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints